March 24 Business Watch: Helium Capacity Taken Out in Qatar; Novartis to Pay $2 Billion for Small Molecule

Pharmaceutical services firms unveiled major manufacturing expansions at DCAT Week, including Cambrex's $130 million API project in Iowa and BSP Pharmaceuticals' $800 million investment in antibody-drug conjugate capabilities.